[AI Generated AI in Drug Discovery News]

• Dimension has secured $500 million to fund approximately 24 companies, aiming to integrate computational power with life sciences to accelerate drug discovery.
• The BiopharmaTrend 2026 watchlist identifies startups founded in 2021 that are using AI platforms to move away from single-asset strategies toward more precise, platform-based drug development.
• Y Combinator is backing the Yale spinout Patientdesk.ai, which utilizes "Agentic AI" to eliminate inefficiencies and improve data-driven forecasting within clinical trials.